160 related articles for article (PubMed ID: 14704865)
1. Pharmacological treatment of diabetic patients with respect to prevention of macrovascular disease.
Tkác T
Acta Diabetol; 2003 Dec; 40 Suppl 2():S338-42. PubMed ID: 14704865
[TBL] [Abstract][Full Text] [Related]
2. Prevention of coronary heart disease in type 2 diabetes.
Mykkänen L
Int J Clin Pract Suppl; 2000 Oct; (113):40-5. PubMed ID: 11965831
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Rosenberg DE; Jabbour SA; Goldstein BJ
Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
Nathanson D; Nyström T
Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
[TBL] [Abstract][Full Text] [Related]
5. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
Leschke M
Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
[TBL] [Abstract][Full Text] [Related]
6. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
Mazzone T
Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones-benefits on microvascular complications of type 2 diabetes.
Viberti G
J Diabetes Complications; 2005; 19(3):168-77. PubMed ID: 15866064
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease.
Ragucci E; Zonszein J; Frishman WH
Heart Dis; 2003; 5(1):18-33. PubMed ID: 12549986
[TBL] [Abstract][Full Text] [Related]
9. [Hypoglycemic treatment of type 2 diabetes].
Thorsby P; Kilhovd B; Sletmo R; Martinsen S; Birkeland KI
Tidsskr Nor Laegeforen; 2000 Aug; 120(20):2434-40. PubMed ID: 11475233
[TBL] [Abstract][Full Text] [Related]
10. [Type 2 diabetes mellitus and cardiovascular diseases: evaluation, treatment and prevention strategies].
Mosseri MM; Fisman EZ; Tenenbaum A
Harefuah; 2006 Feb; 145(2):141-6, 164. PubMed ID: 16509421
[TBL] [Abstract][Full Text] [Related]
11. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
Fonseca VA
Am J Med; 2007 Sep; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
[TBL] [Abstract][Full Text] [Related]
12. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
13. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
Hemmingsen B; Lund SS; Vaag A
Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis.
Tkác I
Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S2-9. PubMed ID: 15955370
[TBL] [Abstract][Full Text] [Related]
15. [Infarct prevention for diabetics. To lower blood sugar is not enough].
MMW Fortschr Med; 2001 Nov; 143(46):61. PubMed ID: 11759608
[No Abstract] [Full Text] [Related]
16. Stroke prevention in diabetes and obesity.
Kurukulasuriya LR; Govindarajan G; Sowers J
Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):487-502. PubMed ID: 16918267
[TBL] [Abstract][Full Text] [Related]
17. Stroke in patients with diabetes mellitus.
Mankovsky BN; Ziegler D
Diabetes Metab Res Rev; 2004; 20(4):268-87. PubMed ID: 15250030
[TBL] [Abstract][Full Text] [Related]
18. Gestational diabetes, pregnancy hypertension, and late vascular disease.
Carpenter MW
Diabetes Care; 2007 Jul; 30 Suppl 2():S246-50. PubMed ID: 17596480
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes mellitus: prevention of macrovascular complications.
Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
[TBL] [Abstract][Full Text] [Related]
20. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
Juhaeri J; Gao S; Dai WS
Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
